180 related articles for article (PubMed ID: 32023222)
21. Increased argonaute 2 expression in gliomas and its association with tumor progression and poor prognosis.
Feng B; Hu P; Lu SJ; Chen JB; Ge RL
Asian Pac J Cancer Prev; 2014; 15(9):4079-83. PubMed ID: 24935600
[TBL] [Abstract][Full Text] [Related]
22. Cytoplasmic expression of BAP1 as an independent prognostic biomarker for patients with gliomas.
Zhang XK; Xi SY; Sai K; Chen HD; Zhong ZH; Wu QL; Zeng J
Int J Clin Exp Pathol; 2015; 8(5):5035-43. PubMed ID: 26191197
[TBL] [Abstract][Full Text] [Related]
23. Identification of a five B cell-associated gene prognostic and predictive signature for advanced glioma patients harboring immunosuppressive subtype preference.
Zhang C; Li J; Wang H; Song SW
Oncotarget; 2016 Nov; 7(45):73971-73983. PubMed ID: 27738332
[TBL] [Abstract][Full Text] [Related]
24. Phosphohistone H3 (pHH3) is a prognostic and epithelial to mesenchymal transition marker in diffuse gliomas.
Zhu P; Zhang CB; Yang P; Chen J; Liu YQ; Hu HM; Huang H; Bao ZS; Zhang W; Kong WJ; Jiang T
Oncotarget; 2016 Jul; 7(29):45005-45014. PubMed ID: 27323851
[TBL] [Abstract][Full Text] [Related]
25. Concomitant microRNA-31 downregulation and radixin upregulation predicts advanced tumor progression and unfavorable prognosis in patients with gliomas.
Wang S; Jiao B; Geng S; Song J; Liang Z; Lu S
J Neurol Sci; 2014 Mar; 338(1-2):71-6. PubMed ID: 24380686
[TBL] [Abstract][Full Text] [Related]
26. Expression of indoleamine 2,3-dioxygenase and correlation with pathological malignancy in gliomas.
Mitsuka K; Kawataki T; Satoh E; Asahara T; Horikoshi T; Kinouchi H
Neurosurgery; 2013 Jun; 72(6):1031-8; discussion 1038-9. PubMed ID: 23426156
[TBL] [Abstract][Full Text] [Related]
27. Identification and validation of a 21-mRNA prognostic signature in diffuse lower-grade gliomas.
Song LR; Weng JC; Huo XL; Wang L; Li H; Li D; Wu Z; Zhang JT
J Neurooncol; 2020 Jan; 146(1):207-217. PubMed ID: 31853837
[TBL] [Abstract][Full Text] [Related]
28. Neural stem cell markers, nestin and musashi proteins, in the progression of human glioma: correlation of nestin with prognosis of patient survival.
Strojnik T; Røsland GV; Sakariassen PO; Kavalar R; Lah T
Surg Neurol; 2007 Aug; 68(2):133-43; discussion 143-4. PubMed ID: 17537489
[TBL] [Abstract][Full Text] [Related]
29. Up-Regulation of Long Non-Coding RNA AB073614 Predicts a Poor Prognosis in Patients with Glioma.
Hu L; Lv QL; Chen SH; Sun B; Qu Q; Cheng L; Guo Y; Zhou HH; Fan L
Int J Environ Res Public Health; 2016 Apr; 13(4):433. PubMed ID: 27104549
[TBL] [Abstract][Full Text] [Related]
30. Protein Disulfide-Isomerase A3 Is a Robust Prognostic Biomarker for Cancers and Predicts the Immunotherapy Response Effectively.
Tu Z; Ouyang Q; Long X; Wu L; Li J; Zhu X; Huang K
Front Immunol; 2022; 13():837512. PubMed ID: 35401558
[TBL] [Abstract][Full Text] [Related]
31. A four-protein expression prognostic signature predicts clinical outcome of lower-grade glioma.
Patil V; Mahalingam K
Gene; 2018 Dec; 679():57-64. PubMed ID: 30077762
[TBL] [Abstract][Full Text] [Related]
32. Long noncoding RNA LINC01426 promotes glioma progression through PI3K/AKT signaling pathway and serves as a prognostic biomarker.
Wang SJ; Wang H; Zhao CD; Li R
Eur Rev Med Pharmacol Sci; 2018 Oct; 22(19):6358-6368. PubMed ID: 30338804
[TBL] [Abstract][Full Text] [Related]
33. The "go or grow" potential of gliomas is linked to the neuropeptide processing enzyme carboxypeptidase E and mediated by metabolic stress.
Höring E; Harter PN; Seznec J; Schittenhelm J; Bühring HJ; Bhattacharyya S; von Hattingen E; Zachskorn C; Mittelbronn M; Naumann U
Acta Neuropathol; 2012 Jul; 124(1):83-97. PubMed ID: 22249620
[TBL] [Abstract][Full Text] [Related]
34. Prognostic significance of glutathione S-transferase pi expression and subcellular localization in human gliomas.
Ali-Osman F; Brunner JM; Kutluk TM; Hess K
Clin Cancer Res; 1997 Dec; 3(12 Pt 1):2253-61. PubMed ID: 9815622
[TBL] [Abstract][Full Text] [Related]
35. High expression of forkhead box protein C2 is related to poor prognosis in human gliomas.
Wang YW; Yin CL; Zhang HY; Hao J; Yang YY; Liao H; Jiao BH
Asian Pac J Cancer Prev; 2014; 15(24):10621-5. PubMed ID: 25605149
[TBL] [Abstract][Full Text] [Related]
36. DDX3X Biomarker Correlates with Poor Survival in Human Gliomas.
Hueng DY; Tsai WC; Chiou HY; Feng SW; Lin C; Li YF; Huang LC; Lin MH
Int J Mol Sci; 2015 Jul; 16(7):15578-91. PubMed ID: 26184164
[TBL] [Abstract][Full Text] [Related]
37. Collaborative overexpression of matrix metalloproteinase-1 and vascular endothelial growth factor-C predicts adverse prognosis in patients with gliomas.
Xu Y; Zhong Z; Yuan J; Zhang Z; Wei Q; Song W; Chen H
Cancer Epidemiol; 2013 Oct; 37(5):697-702. PubMed ID: 23870768
[TBL] [Abstract][Full Text] [Related]
38. Impact of a novel biomarker, T-LAK cell-originating protein kinase (TOPK) expression on outcome in malignant glioma.
Hayashi T; Hayakawa Y; Koh M; Tomita T; Nagai S; Kashiwazaki D; Sugimori M; Origasa H; Kuroda S
Neuropathology; 2018 Apr; 38(2):144-153. PubMed ID: 29271010
[TBL] [Abstract][Full Text] [Related]
39. The Hedgehog signalling pathway and its prognostic impact in human gliomas.
Li Q; Zhang Y; Zhan H; Yuan Z; Lu P; Zhan L; Xu W
ANZ J Surg; 2011 Jun; 81(6):440-5. PubMed ID: 22295347
[TBL] [Abstract][Full Text] [Related]
40. Slit2 and Robo1 expression as biomarkers for assessing prognosis in brain glioma patients.
Liu L; Li W; Geng S; Fang Y; Sun Z; Hu H; Liang Z; Yan Z
Surg Oncol; 2016 Dec; 25(4):405-410. PubMed ID: 27916173
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
